tation in a patient with myelodysplastic transformation of FA, using modified conditioning with 'intermediate' dose BU and CY. We report an 11-year old female with myelodysplastic (refractory anemia with excess of blasts) presentation of Fanconi anemia. After failure of initial chemotherapy with low doses of 6-mercaptopurine and prednisolone Case report she underwent allogeneic bone marrow transplantation (BMT) from her HLA-matched sibling. Busulfan
/l platelets. Fanconi anemia (FA) is a rare autosomal recessive disease, Bone marrow aspiration from two sites (sternum and poscharacterized by developmental malformations, bone marterior iliac crest) revealed markedly reduced cellularity with row hypoplasia 1 and frequent development of clonal hemo-9-20% blast cells, 30% myeloid cells, 20% monocytes, poietic abnormalities -myelodysplasias and nonlympho-23% erythroid cells, and 10% lymphocytes, respectively. cytic leukemias. 2, 3 The treatment of choice for bone Morphologically, the blast cells appeared to be monoblasts. marrow failure in FA is allogeneic bone marrow transplanCells of the myeloid line showed unequivocal dysplastic tation from an HLA-compatible sibling. One of the most features: hypogranularity, nuclear hypersegmentation, successful conditioning regimen combines low-dose cyclocellular gigantism, cytoplasmic vacuolation. Megaphosphamide (CY) and low-dose thoracoabdominal karyocytes were present in sufficient numbers, but were irradiation (TAI) and leads to approximately 75% long-term severely dyspoietic with mononuclear and microforms. survival rate. 4 However, for patients with FA, developing Dyserythropoiesis was not present. On trephine biopsy, leukemic or myelodysplastic transformation, results of bone cellularity of the bone marrow was decreased to 5-30% marrow transplantation are much less encouraging with less in different areas with predominance of lymphocytes and than half of patients surviving. 5 She was febrile at 39°C and examination revealed exten-sive hyperplastic gingivitis, initially thought to be leukemic tivity test shows 100% 46 XY with 0.06 chromosomal breaks per cell. BM cytogenetic examination shows a 46 gum involvement but which on biopsy proved to be reactive. Pseudomonas aeruginosa was grown from the XY karyotype without structural chromosomal abnormalities in 100% of metaphases. Blood biochemical analysis contents of dental pockets. She was treated with appropriate antibiotics, prednisolone 25 mg/day and 6-mercaptopurine shows SGOT 32 UI/l, SGPT 28 UI/l, LDH 525 UI/l, alkaline phosphatase 623 UI/l and bilirubin 12 mol/l. 12.5 mg/day for 3 months with a slight rise of hemoglobin and granulocytes Ͼ500/mm 3 . She became transfusion independent, but continued to be severely thrombocytopenic Discussion and the blast count in BM remained virtually unchanged. She was therefore scheduled for BMT from her 6-year-old Bone marrow transplantation from an HLA-identical sibling is the only curative treatment for the hypoplastic ane-HLA-identical, DEB-negative (0.04 break per cell) brother. mia in patients with Fanconi anemia. Using low-dose irradiation and low-dose CY as conditioning, and CsA alone as GVHD prophylaxis results in over 75% survival.
Bone marrow transplantation procedure
However, experience with BMT in patients with myelodysplastic transformation of FA is limited and they generally The patient received conditioning with busulfan 1 mg/kg every 6 h to a total dose of 8 mg/kg on days −7 and −6, fare worse than those with 'uncomplicated' hypoplasia. Ikushima et al 5 summarized reports on 13 patients grafted and cyclophosphamide 10 mg/kg day from days −5 to −2 (total dose 40 mg/kg). GVHD prevention consisted of CsA for FA-MDS: three successful cases were conditioned with regimens developed by Gluckman et al containing low alone started on day −1 at a dose 5 mg/kg day intravenously, divided into two doses. The patient was nursed doses of TAI, TLI or TBI and low-dose cyclophosphamide, and two patients received more aggressive conditioning. 5, 8, 9 in laminar air flow with HEPA filters. Supportive measures included antibacterial and antifungal prophylaxis with cipTwo patients were conditioned with busulfan 8 mg/kg and TLI -one of them survived. 10 More aggressive conditionrofloxacin, diflucan and amphotericin B orally, with acyclovir 250 mg/m 2 every 8 h i.v. from day +1, according to the ing with TBI 12 Gy and cyclophosphamide 120 mg/kg or busulfan 14-16 mg and CY 100-150 mg/kg almost uniinstitutional protocol. Since both donor and recipient were CMV-IgG positive, ganciclovir 10 mg/kg day i.v. was formly failed. 9,11 BU 8 mg/kg + CY 40 mg/kg conditioning was used by the Paris team for a second marrow transplant given from days −8 to −1 and then CMV reactivation was monitored weekly by PCR. On day 0 she received unmanin a patient with FA who failed to engraft after TAI 5 Gy + CY (Gluckman et al, unpublished) . There are no ipulated bone marrow with 3.1 × 10 8 nucleated cells/kg b.w. The post-BMT course was uneventful, except for modreports on MDS recurrence after BMT for FA-MDS and all failures were, in fact, caused by toxicity related to conerate oral mucositis and esophagitis treated with narcotics and antacids, and fever of unknown origin, treated with ditioning. Moreover, using TBI, even in reduced doses, may confer an additional risk of carcinogenesis to FA broad-spectrum antibiotics. Gum hyperplasia resolved completely with the recovery of granulocytes. Grade I-II patients who are predisposed to develop late cancers after successful BMT, 12 causing late failures of treatment. cutaneous GVHD developed on day +10, with reactivation on day +40, controlled with methylprednisolone i.v. 2-Given the increased susceptibility of transformed FA cells to alkylating agents such as cyclophosphamide, there 3 mg/kg day. Engraftment (1 of 3 consecutive days with absolute neutrophils counts Ͼ500/mm 3 ) occurred on day is a rationale for suggesting that 'attenuated' alkylating agent-based conditioning may be sufficient to eradicate the +13. The patient achieved transfusion independence on day +14 both for RBC and platelets. Platelet count of leukemic clone. The case reported here argues in favor of this hypothesis. The patient experienced fast trilineage Ͼ50 000/mm 3 occurred on day +20. Bone marrow aspiration on day +38 showed normal cellularity with 0.2% engraftment without severe nonhematological toxicity and is alive and MDS free 17 months after BMT, with full blasts, 66.8 myeloid cells, 19% erythroid cells, 7% lymphocytes, 7% monocytes and a normal number of megakaryodonor chimerism. It is worth noting, however, that despite the hematologic picture of MDS, no clonal chromosomal cytes. Routine cytogenetic examination of BM revealed 100% 46 XY metaphases. Analysis of phytohemagglutinabnormalities, frequently reported in FA-MDS were found in our patient. This could confer a more favorable progine-stimulated peripheral blood lymphocytes showed mixed chimerism -73% of normal 46XY metaphases and 27% of nosis, by analogy with primary MDS, 13 and conversely, cases with such abnormalities may require more aggressive 46XX metaphases with all female cells bearing multiple chromosomal aberrations, characteristic of FA. On day +90
conditioning. Another concern with the use of chemotherapy based conditioning for BMT of FA is the developperipheral blood lymphocyte karyotype revealed 91% 46XY and 9% of 46XX cells. At the time of writing, 17 ment of serious early or delayed liver toxicity, due to busulfan for this group of patients, who are particularly prone months after BMT, the patient is alive with chronic GVHD, involving skin, muscles and carpal joints. CBC show Hb to develop hepatic tumors. 14 Fortunately our patient has not experienced any hepatic complications. More patients and 131 g/l, RBC 4.01 × 10 12 /l, MCV 81 fl, WBC 19.4 × 10 9 /l with 31% granulocytes, 8% eosinophils, 13% monocytes, prolonged follow-up are necessary to answer this question.
In conclusion, the case reported here highlights questions 48% lymphocytes, 329 × 10 9 /l platelets. BM aspirate reveals marrow of normal cellularity, blast cells -1.8%, arising in every case of MDS-FA and gives an example of successful transplantation with minimally toxic chemonormal ratios of myeloid and erythroid cells with an excess of eosinophils. No dysplastic features are noted. DEB sensitherapy based conditioning therapy.
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